Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Multicentric Extension Study to Assess the Long-term Safety of the Genio® System in Study Subjects Who Have Been Implanted With the Genio® Implantable Stimulator (IS) for the Treatment of OSA in Adult Patients.

NCT05939141 is registered in ClinicalTrials.gov with Nyxoah S.A. as lead sponsor.

NCT NCT05939141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Multicentric Extension Study to Assess the Long-term Safety of the Genio® System in Study Subjects Who Have Been Implanted With the Genio® Implantable Stimulator (IS) for the Treatment of OSA in Adult Patients.
Lead sponsor
Nyxoah S.A.
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2025
Completion date
July 17, 2029
Enrollment
39 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea of adult